Chana L. Glasser
Island Hospital(US)New York University(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, Protein Degradation and Inhibitors, Hematological disorders and diagnostics
Most-Cited Works
- → Characterization of COVID‐19 disease in pediatric oncology patients: The New York‐New Jersey regional experience(2020)117 cited
- → Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma(2020)70 cited
- → Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience(2017)48 cited
- → Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution’s Experience(2017)43 cited
- → New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)(2020)37 cited
- → Phenotypic Heterogeneity of Neutropenia and Gastrointestinal Illness Associated with G6PC3 Founder Mutation(2016)14 cited
- → Epigenetic Combination Therapy for Children With Secondary Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) and Concurrent Solid Tumor Relapse(2017)12 cited
- → IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children’s oncology group report(2022)11 cited
- → Clinical Features and Risk Factors Associated With Multisystem Inflammatory Syndrome in Children With Cancer and COVID-19(2023)9 cited
- → Seasonal variation of respiratory viral infections: a comparative study between children with cancer undergoing chemotherapy and children without cancer(2021)7 cited